A Phase II Study of Etanercept (Enbrel), a Tumor Necrosis Factor α Inhibitor in Patients with Metastatic Breast CancerSrinivasan Madhusudan, Adrian L. Harris, S. Muthuramalingam et al.|Clinical Cancer Research|2004Cited by 204